MedPath

Efficiency of Evening Primrose Oil on Operative Hysteroscopy

Phase 3
Conditions
Hysteroscopy surgical facilitation.
Registration Number
IRCT20080910001233N5
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
160
Inclusion Criteria

Women candidates for hysteroscopy

Exclusion Criteria

People who need laparoscopy
Pregnant women
Existence of systemic diseases
infection of cervix
Existence of cervical anomalies
Existence of Mullerian anomalies
Contraindication prostaglandins.
patients with bleeding disorders
consumers of anticoagulants
patients with schizophrenia who use phenothiazine
patients With epilepsy
patients With blood pressure
People who need abdominal hysterectomy
infection of vaginal
Existence of cervical insufficiency
Existence of history of cervical biopsy
cesarean delivery
History of allergies to evening primros

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
First resistance interval. Timepoint: Interval of first resistance based on duration to size of hegar dilator rejected without cervical resistance. Method of measurement: second.;Duration of dilatation to reach Hegar size 10. Timepoint: Interval from start of hysteroscopy hegar to create dilatation. Method of measurement: second.;Duration of hysteroscopy operation. Timepoint: Interval from the time of importing bogey to finishing importing bogey. Method of measurement: Minute.;First hegar size. Timepoint: During hysteroscopy. Method of measurement: Based on maximum dilator size (hegar),Which can be passed internal os without resistance.;Ease of dilatation. Timepoint: During hysteroscopy. Method of measurement: Base on a 5-point Likert scale (excellent, good, average, poor, very poor).;Requires mechanical dilatation. Timepoint: During hysteroscopy. Method of measurement: Based on clinical examination.
Secondary Outcome Measures
NameTimeMethod
terine and cervicovaginal complications (bleeding, uterine rupture, cervical rupture,false way ) during surgery. Timepoint: during surgery. Method of measurement: See any of the unusual complications: bleeding , uterine rupture, cervical rupture,false way.;Side effects related to the drug used. Timepoint: ?During operation up to 24 hours after surgery. Method of measurement: Occurrence of any of the following undesirable effects: allergic reactions, abdominal pain, nausea, diarrhea, headache, increased bowel movements.;Preoperative pain from medication. Timepoint: Immediately before surgery. Method of measurement: Scoring for pain by the patient using VSA (Zero = no pain) and (ten = unbearable pain).
© Copyright 2025. All Rights Reserved by MedPath